• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur Radiol. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19)

tetano

Editor, Senior Moderator
Eur Radiol. 2020 Mar 25. doi: 10.1007/s00330-020-06817-6. [Epub ahead of print]
CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19).


Li K[SUP]1,[/SUP][SUP]2[/SUP], Fang Y[SUP]1,[/SUP][SUP]2[/SUP], Li W[SUP]1,[/SUP][SUP]2[/SUP], Pan C[SUP]1,[/SUP][SUP]2[/SUP], Qin P[SUP]1,[/SUP][SUP]2[/SUP], Zhong Y[SUP]1,[/SUP][SUP]2[/SUP], Liu X[SUP]1,[/SUP][SUP]2[/SUP], Huang M[SUP]3[/SUP], Liao Y[SUP]4[/SUP], Li S[SUP]5,[/SUP][SUP]6[/SUP].

Author information




Abstract

OBJECTIVES:

To explore the relationship between the imaging manifestations and clinical classification of COVID-19.
METHODS:

We conducted a retrospective single-center study on patients with COVID-19 from Jan. 18, 2020 to Feb. 7, 2020 in Zhuhai, China. Patients were divided into 3 types based on Chinese guideline: mild (patients with minimal symptoms and negative CT findings), common, and severe-critical (patients with positive CT findings and different extent of clinical manifestations). CT visual quantitative evaluation was based on summing up the acute lung inflammatory lesions involving each lobe, which was scored as 0 (0%), 1 (1-25%), 2 (26-50%), 3 (51-75%), or 4 (76-100%), respectively. The total severity score (TSS) was reached by summing the five lobe scores. The consistency of two observers was evaluated. The TSS was compared with the clinical classification. ROC was used to test the diagnosis ability of TSS for severe-critical type.
RESULTS:

This study included 78 patients, 38 males and 40 females. There were 24 mild (30.8%), 46 common (59.0%), and 8 severe-critical (10.2%) cases, respectively. The median TSS of severe-critical-type group was significantly higher than common type (p < 0.001). The ICC value of the two observers was 0.976 (95% CI 0.962-0.985). ROC analysis showed the area under the curve (AUC) of TSS for diagnosing severe-critical type was 0.918. The TSS cutoff of 7.5 had 82.6% sensitivity and 100% specificity.
CONCLUSIONS:

The proportion of clinical mild-type patients with COVID-19 was relatively high; CT was not suitable for independent screening tool. The CT visual quantitative analysis has high consistency and can reflect the clinical classification of COVID-19.
KEY POINTS:

• CT visual quantitative evaluation has high consistency (ICC value of 0.976) among the observers. The median TSS of severe-critical type group was significantly higher than common type (p < 0.001). • ROC analysis showed the area under the curve (AUC) of TSS for diagnosing severe-critical type was 0.918 (95% CI 0.843-0.994). The TSS cutoff of 7.5 had 82.6% sensitivity and 100% specificity. • The proportion of confirmed COVID-19 patients with normal chest CT was relatively high (30.8%); CT was not a suitable screening modality.



KEYWORDS:

COVID-19; Classification; Quantitative evaluation; Tomography, X-ray computed


PMID:32215691DOI:10.1007/s00330-020-06817-6
 
Back
Top